04/21/2026
New data support maternal RSV vaccination to protect infants
A study presented at the European Society of Clinical Microbiology and Infectious Diseases' Global Congress associated maternal vaccination against respiratory syncytial virus with an 81.3% reduction in infant hospitalizations when given at least two weeks before birth. The study analyzed data on almost 290,000 infants born from September 2024 to March 2025.